| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |